Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Leukemia Research|February 12, 2022
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experienceEleonora De Bellis, Silvia Imbergamo, Anna Candoni, et al.
Vaccine|March 23, 2010
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancerMatteo Martini, Maria Grazia Testi, Matteo Pasetto, et al.
Cancers|October 27, 2022
Doped Ferrite Nanoparticles Exhibiting Self-Regulating Temperature as Magnetic Fluid Hyperthermia Antitumoral Agents, with Diagnostic Capability in Magnetic Resonance Imaging and Magnetic Particle ImagingFederica Vurro, Marco Gerosa, Alice Busato, et al.
Bone Marrow Transplantation|May 5, 2022
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter seriesMichele Wieczorek, Sara Mariotto, Sergio Ferrari, et al.
Circulation Research|October 10, 2009
Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heartDavid A D'Alessandro, Jan Kajstura, Toru Hosoda, et al.
Frontiers in Oncology|January 25, 2021
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple MyelomaAnna Russignan, Giada Dal Collo, Anna Bagnato, et al.
Frontiers in Oncology|June 21, 2021
Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid LeukemiaGiorgia Simonetti, Davide Angeli, Elisabetta Petracci, et al.
Leukemia Research|December 12, 2018
Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experienceCarla Filì, Anna Candoni, Maria Elena Zannier, et al.
Journal of Clinical Medicine|February 13, 2025
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian CentersGiulia Battaglia, Davide Lazzarotto, Ilaria Tanasi, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 6, 2017
Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemiaAndrea Piccin, Michael Steurer, Clemens Feistritzer, et al.
Pageof 9